UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

Journal of hepatology, 2016-10, Vol.65 (4), p.692-699

2016

Link zum Volltext

Verfügbarkeit prüfen

Serum Level of IP-10 Increases Predictive Value of IL28B Polymorphisms for Spontaneous Clearance of Acute HCV Infection

Gastroenterology (New York, N.Y. 1943), 2012, Vol.142 (1), p.78-85.e2

2012

Link zum Volltext

Verfügbarkeit prüfen

Real-Time PCR Assays for the Quantification of HCV RNA: Concordance, Discrepancies and Implications for Response Guided Therapy

PloS one, 2015-08, Vol.10 (8), p.e0135963-e0135963

2015

Link zum Volltext

Verfügbarkeit prüfen

MedUni Wien Researcher of the Month, Februar 2013

Wiener Klinische Wochenschrift, 2013-02, Vol.125 (3-4), p.115-116

Beinhardt, Sandra

2013

Link zum Volltext

Verfügbarkeit prüfen

IL28B polymorphism cannot predict response to interferon alpha treatment in patients with melanoma

PloS one, 2014-11, Vol.9 (11), p.e112613-e112613

2014

Link zum Volltext

Verfügbarkeit prüfen

Silibinin: An old drug in the high tech era of liver transplantation

Journal of hepatology, 2013-03, Vol.58 (3), p.409-411

2013

Link zum Volltext

Verfügbarkeit prüfen

Pregnancy in Wilson's disease: Management and outcome

Hepatology (Baltimore, Md.), 2018-04, Vol.67 (4), p.1261-1269

2018

Link zum Volltext

Verfügbarkeit prüfen

Silibinin monotherapy prevents graft infection after orthotopic liver transplantation in a patient with chronic hepatitis C

Journal of hepatology, 2011-03, Vol.54 (3), p.591-592

2011

Link zum Volltext

Verfügbarkeit prüfen

Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy

Gastroenterology (New York, N.Y. 1943), 2008-11, Vol.135 (5), p.1561-1567

2008

Link zum Volltext

Verfügbarkeit prüfen

Follow‐up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin‐free treatment

Liver international, 2018-06, Vol.38 (6), p.1028-1035

2018

Link zum Volltext

Verfügbarkeit prüfen

High seroprevalence of anti‐Hepatitis E antibodies in Austrian patients with autoimmune hepatitis

Liver international, 2019-04, Vol.39 (4), p.640-645

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naïve Patients With Chronic Hepatitis C

Clinical gastroenterology and hepatology, 2011-04, Vol.9 (4), p.344-350.e2

2011

Link zum Volltext

Verfügbarkeit prüfen

DAA‐based antiviral treatment of patients with chronic hepatitis C in the pre‐ and postkidney transplantation setting

Transplant international, 2016-09, Vol.29 (9), p.999-1007

2016

Link zum Volltext

Verfügbarkeit prüfen

Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin

Journal of hepatology, 2011-05, Vol.54 (5), p.866-871

2011

Link zum Volltext

Verfügbarkeit prüfen

Revisiting the Predictors of a Sustained Virologic Response in the Era of Direct-Acting Antiviral Therapy for Hepatitis C Virus

Clinical infectious diseases, 2013-01, Vol.56 (1), p.118-122

2013

Link zum Volltext

Verfügbarkeit prüfen

Portal Pressure Predicts Outcome and Safety of Antiviral Therapy in Cirrhotic Patients With Hepatitis C Virus Infection

Clinical gastroenterology and hepatology, 2011-07, Vol.9 (7), p.602-608.e1

2011

Link zum Volltext

Verfügbarkeit prüfen

Haemophagocytic lymphohistiocytosis associated with fulminant hepatitis and multiorgan failure following primary Epstein–Barr virus and herpes simplex virus type 1 infection

BMJ case reports, 2017-03, Vol.2017, p.bcr2016218310

2017

Link zum Volltext

Verfügbarkeit prüfen

Interferon‐free antiviral treatment of chronic hepatitis C in the transplant setting

Transplant international, 2015-09, Vol.28 (9), p.1011-1024

2015

Link zum Volltext

Verfügbarkeit prüfen

Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C

Journal of hepatology, 2012-09, Vol.57 (3), p.492-498

2012

Link zum Volltext

Verfügbarkeit prüfen

Long‐term follow‐up of ribavirin‐free DAA‐based treatment in HCV recurrence after orthotopic liver transplantation

Liver international, 2018-07, Vol.38 (7), p.1188-1197

2018

Link zum Volltext

Verfügbarkeit prüfen

A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infection

Journal of hepatology, 2013-11, Vol.59 (5), p.972-977

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients

Journal of hepatology, 2013-11, Vol.59 (5), p.964-971

2013

Link zum Volltext

Verfügbarkeit prüfen

Treatment of chronic hepatitis C genotype 1 patients at an academic center in europe involved in prospective, controlled trials: Is there a selection bias?

Hepatology (Baltimore, Md.), 2012-01, Vol.55 (1), p.30-38

2012

Link zum Volltext

Verfügbarkeit prüfen

Intravenous silibinin as 'rescue treatment' for on-treatment non-responders to pegylated interferon/ribavirin combination therapy

Antiviral therapy, 2011-01, Vol.16 (8), p.1327-1333

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(36)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Humans
(22)
Life Sciences & Biomedicine
(21)
Male
(20)
Female
(19)
Gastroenterology And Hepatology
(18)
Gastroenterology & Hepatology
(17)
Middle Aged
(16)
Hepatitis C, Chronic - Drug Therapy
(14)
Adult
(13)
Interferons
(13)
Antiviral Agents - Therapeutic Use
(12)
Interleukins - Genetics
(10)
Hepatitis C Virus
(9)
Genotype
(8)
Hepatitis
(8)
Hepatitis C
(8)
Treatment Outcome
(8)
Interferon-Alpha - Therapeutic Use
(7)
Patients
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

Serum Level of IP-10 Increases Predictive Value of IL28B Polymorphisms for Spontaneous Clearance of Acute HCV Infection

Real-Time PCR Assays for the Quantification of HCV RNA: Concordance, Discrepancies and Implications for Response Guided Therapy

MedUni Wien Researcher of the Month, Februar 2013

IL28B polymorphism cannot predict response to interferon alpha treatment in patients with melanoma

Silibinin: An old drug in the high tech era of liver transplantation

Pregnancy in Wilson's disease: Management and outcome

Silibinin monotherapy prevents graft infection after orthotopic liver transplantation in a patient with chronic hepatitis C

Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy

Follow‐up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin‐free treatment

High seroprevalence of anti‐Hepatitis E antibodies in Austrian patients with autoimmune hepatitis

Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naïve Patients With Chronic Hepatitis C

DAA‐based antiviral treatment of patients with chronic hepatitis C in the pre‐ and postkidney transplantation setting

Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin

Revisiting the Predictors of a Sustained Virologic Response in the Era of Direct-Acting Antiviral Therapy for Hepatitis C Virus

Portal Pressure Predicts Outcome and Safety of Antiviral Therapy in Cirrhotic Patients With Hepatitis C Virus Infection

Haemophagocytic lymphohistiocytosis associated with fulminant hepatitis and multiorgan failure following primary Epstein–Barr virus and herpes simplex virus type 1 infection

Interferon‐free antiviral treatment of chronic hepatitis C in the transplant setting

Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C

Long‐term follow‐up of ribavirin‐free DAA‐based treatment in HCV recurrence after orthotopic liver transplantation

A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infection

Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients

Treatment of chronic hepatitis C genotype 1 patients at an academic center in europe involved in prospective, controlled trials: Is there a selection bias?

Intravenous silibinin as 'rescue treatment' for on-treatment non-responders to pegylated interferon/ribavirin combination therapy

Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with SVR following IFN-free DAA treatment

Suchergebnisse filtern